("Prospex" or the "Company")
Issue of Equity
Directors Dealing
The Company is pleased to announce the issue of 10,000,000 new ordinary shares at 1p per share ("New Ordinary Shares") raising
The Subscription was fully subscribed for by the Directors of the Company, on the same terms as the placing of new ordinary shares as announced by the Company on
Following the announcement today of the final results of the Company, the Directors of the Company have purchased new ordinary shares, as set out below:
Director |
Number of Ordinary Shares Purchased |
Price per Ordinary Share |
Resulting Beneficial Holding, Ordinary Shares |
Holding as a Percentage of Company's Issued Share Capital |
|
1,000,000 |
1p |
2,639,344 |
1.23% |
|
1,500,000 |
1p |
2,811,474 |
1.31% |
|
7,500,000 |
1p |
9,139,344 |
4.24% |
"We are pleased to have participated in the Company's funding and look forward to the well being drilled later this year. We believe the investment in
Application will be made for the New Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on
Following the issue of the New Ordinary Shares, the total number of shares in issue is 215,331,291 New Ordinary Shares. There are no shares held in treasury. Therefore, the total number of voting rights in the Company is 215,331,291. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest under the Disclosure and Transparency Rules.
|
|
|
0207 887 1461 |
|
|
|
|
|
0113 394 6600 |
|
0207 220 1658 |
|
|
|
0207 469 0932 |
|
0207 382 8300 |
|
|
This information is provided by RNS